Abstract:Background: Polygenic risk scores (PRS) are tools used to evaluate an individual's susceptibility to polygenic diseases based on their genetic profile. A considerable proportion of people carry a high genetic risk but evade the disease. On the other hand, some individuals with a low risk of eventually developing the disease. We hypothesized that unknown counterfactors might be involved in reversing the PRS prediction, which might provide new insights into the pathogenesis, prevention, and early intervention of diseases. Methods: We built a novel computational framework to identify genetically-regulated pathways (GRPas) using PRS-based stratification for each cohort. We curated two AD cohorts with genotyping data; the discovery (disc) and the replication (rep) datasets include 2722 and 2854 individuals, respectively. First, we calculated the optimized PRS model based on the three recent AD GWAS summary statistics for each cohort. Then, we stratified the individuals by their PRS and clinical diagnosis into six biologically meaningful PRS strata, such as AD cases with low/high risk and cognitively normal (CN) with low/high risk. Lastly, we imputed individual genetically-regulated expression (GReX) and identified differential GReX and GRPas between risk strata using gene-set enrichment and variational analyses in two models, with and without APOE effects. An orthogonality test was further conducted to verify those GRPas are independent of PRS risk. To verify the generalizability of other polygenic diseases, we further applied a default model of GRPa-PRS for schizophrenia (SCZ). Results: For each stratum, we conducted the same procedures in both the disc and rep datasets for comparison. In AD, we identified several well-known AD-related pathways, including amyloid-beta clearance, tau protein binding, and astrocyte response to oxidative stress. Additionally, we discovered resilience-related GRPs that are orthogonal to AD PRS, such as the calcium signaling pathway and divalent inorganic cation homeostasis. In SCZ, pathways related to mitochondrial function and muscle development were highlighted. Finally, our GRPa-PRS method identified more consistent differential pathways compared to another variant-based pathway PRS method. Conclusions: We developed a framework, GRPa-PRS, to systematically explore the differential GReX and GRPas among individuals stratified by their estimated PRS. The GReX-level comparison among those strata unveiled new insights into the pathways associated with disease risk and resilience. Our framework is extendable to other polygenic complex diseases.

Enhancing Portability of Trans-Ancestral Polygenic Risk Scores through Tissue-Specific Functional Genomic Data Integration

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Polygenic risk score portability for common diseases across genetically diverse populations

Principles and methods for transferring polygenic risk scores across global populations

Integration of Rare Large-Effect Expression Variants Improves Polygenic Risk Prediction

Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data

Deconvolution of polygenic risk score in single cells unravels cellular and molecular heterogeneity of complex human diseases

Leveraging functional genomic annotations and genome coverage to improve polygenic prediction of complex traits within and between ancestries

A Novel Transcriptional Risk Score for Risk Prediction of Complex Human Diseases

Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations

Implementing polygenic risk scores in the clinic

Effective Genetic Risk Prediction Using Mixed Models

The expected polygenic risk score (ePRS) framework: an equitable metric for quantifying polygenetic risk via modeling of ancestral makeup

Integration of Rare Expression Outlier-Associated Variants Improves Polygenic Risk Prediction.

Methodologies underpinning polygenic risk scores estimation: a comprehensive overview

Leveraging trans-ethnic genetic risk scores to improve association power for complex traits in underrepresented populations

Improving polygenic risk prediction in admixed populations by explicitly modeling ancestral-differential effects via GAUDI

GRPa-PRS: A risk stratification method to identify genetically-regulated pathways in polygenic diseases

Regsnps: a Strategy for Prioritizing Regulatory Single Nucleotide Substitutions.

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions